To include your compound in the COVID-19 Resource Center, submit it here.

Asieris raises series B round

Asieris Pharmaceuticals Co. Ltd. (Taizhou, China) said on Dec. 27, 2017, that

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE